Clinical Trials
14 trialsNCT02203552 2025-01-08
Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT01283997 2024-06-13
Prevention of Treatment Induced Neuropathy in Multiple Myeloma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT04721626 2022-02-07
Topical Antisepsis in Head and Neck Cancer Surgery
Medical College of Wisconsin
Completed
NCT02297412 2022-01-31
Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel
Academic and Community Cancer Research United
Phase 2 Completed
NCT01793051 2021-11-24
Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02770378 2021-10-05
A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
University of Ulm
Phase 1/2 Completed
NCT01173692 2021-08-20
Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study.
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01636934 2020-07-17
Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01906008 2020-03-17
Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01693523 2020-03-09
Minocycline Study in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01317550 2020-02-10
A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil
M.D. Anderson Cancer Center
Phase NA Completed
NCT01580969 2019-08-16
RAMBO
University of Utah
Phase 1/2 Completed
NCT01746043 2018-06-06
A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00473083 2017-04-04
LUTRAERL
British Columbia Cancer Agency
Phase 2 Completed